Opportunity
Simpler Grants.gov #RFA-DK-27-117
NIH Solicits Clinical and Data Research Centers for GI Interoception Consortium
Buyer
National Institutes of Health
Posted
September 18, 2025
Respond By
November 01, 2026
Identifier
RFA-DK-27-117
NAICS
541715
The National Institutes of Health (NIH), through the National Institute of Diabetes and Digestive Diseases and Nutrition (NIDDK), is seeking to establish a Disorders of Gastrointestinal Interoception Consortium (DGIC). - Up to six Clinical Research Centers and one Scientific Data Research Center will be funded - Focus is on multidisciplinary research into adult and pediatric gastrointestinal (GI) disorders involving altered interoceptive signaling - Research goals include: - Identifying mechanisms linking GI function to symptoms - Discovering biomarkers for GI interoception disorders - Developing new therapeutic targets - Eligible applicants include higher education institutions, government entities, nonprofits, and businesses - No specific OEMs, vendors, or commercial products are named, as this is a research grant opportunity - Estimated program funding is $3 million - Emphasis on collaborative research, data collection, and coordination across multiple centers
Description
The National Institute of Diabetes and Digestive Diseases and Nutrition (NIDDK) seeks to continue and expand the work of the Gastroparesis Consortium to include other gastrointestinal conditions associated with impaired interoceptive processing. The initiative aims to form a Disorders of Gastrointestinal Interoception Consortium (DGIC) with up to 6 Clinical Research Centers and a Scientific Data Research Center. The focus is on multidisciplinary approaches to understand underlying mechanisms, identify biomarkers, and discover novel therapeutic targets for future clinical trials. The consortium will address both adult and pediatric GI conditions involving altered interoceptive signaling.